May 28, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up to 6 months after COVID-19 infection, according to data published in Arthritis & Rheumatology.“Longer duration of SARS-CoV-2 antigen persistence in the blood has been associated with various outcomes including higher risk of post-acute sequelae of COVID-19,”
May 28, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Yale study links some long COVID patients to autoimmune responses

Serology Affects Transition From Arthralgia to Full-Blown Rheumatoid Arthritis

Understanding the potential of CAR-T therapy in autoimmune disease treatment

Chronic Spontaneous Urticaria Is More Than IgE: New Pathways Drive Targeted Care

Covid prolongado: las secuelas que dejan las reinfecciones y la importancia de la vacunación

CHICAGO — Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced…

ORLANDO — Following hospitalization for an exacerbation of interstitial lung disease related to systemic autoimmune rheumatic…

Breaking news, emerging data, features and Q&As at the intersection of COVID-19 and rheumatology.

A new study co-led by Yale scientists reveals that antibodies from some long COVID patients attacked brain and nerve tissues, a…

ACPA status could inform treatment and preventive strategies

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid and…